Hookipa Historical Income Statement
| HOOK Stock | USD 2.48 0.16 6.90% |
Historical analysis of Hookipa Pharma income statement accounts such as Interest Income of 5.2 M or Depreciation And Amortization of 2.9 M can show how well Hookipa Pharma performed in making a profits. Evaluating Hookipa Pharma income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Hookipa Pharma's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Hookipa Pharma latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Hookipa Pharma is a good buy for the upcoming year.
Hookipa |
About Hookipa Income Statement Analysis
Hookipa Pharma Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Hookipa Pharma shareholders. The income statement also shows Hookipa investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Hookipa Pharma Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Hookipa Pharma. It is also known as Hookipa Pharma overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on Hookipa Pharma income statement and represents the costs associated with goods and services Hookipa Pharma provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most accounts from Hookipa Pharma's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Hookipa Pharma current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hookipa Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.At this time, Hookipa Pharma's Income Tax Expense is quite stable compared to the past year.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 898K | 687K | 317K | 565.6K | Depreciation And Amortization | 4.6M | 3.6M | 3.6M | 2.9M |
Hookipa Pharma income statement Correlations
Click cells to compare fundamentals
Hookipa Pharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Hookipa Pharma income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Tax Provision | (100K) | (109K) | 1K | 230K | 433K | 454.7K | |
| Net Interest Income | 710K | (386K) | (871K) | 946K | 4.6M | 4.8M | |
| Interest Income | 1.6M | 400K | 27K | 1.6M | 5.0M | 5.2M | |
| Depreciation And Amortization | 1.4M | 4.2M | 4.6M | 3.6M | 3.6M | 2.9M | |
| Interest Expense | 877K | 786K | 898K | 687K | 317K | 565.6K | |
| Selling General Administrative | 16.7M | 18.1M | 17.3M | 18.8M | 18.6M | 15.8M | |
| Total Revenue | 11.9M | 19.6M | 18.4M | 14.2M | 20.1M | 14.5M | |
| Gross Profit | 11.9M | 19.6M | 18.4M | 14.2M | 16.6M | 12.4M | |
| Other Operating Expenses | 63.0M | 72.9M | 100.1M | 87.4M | 117.8M | 74.9M | |
| Operating Income | (51.1M) | (53.3M) | (81.7M) | (73.2M) | (97.7M) | (92.8M) | |
| Net Income From Continuing Ops | (43.0M) | (44.1M) | (75.7M) | (64.9M) | (69.1M) | (72.5M) | |
| Ebit | (51.1M) | (53.3M) | (81.7M) | (73.2M) | (80.9M) | (84.9M) | |
| Research Development | 46.3M | 54.8M | 82.9M | 68.6M | 86.4M | 58.3M | |
| Ebitda | (49.6M) | (49.1M) | (77.0M) | (69.6M) | (77.3M) | (81.2M) | |
| Cost Of Revenue | 46.3M | 53.1M | 4.6M | 3.6M | 3.6M | 3.4M | |
| Total Operating Expenses | 63.0M | 72.9M | 100.1M | 87.4M | 117.8M | 74.9M | |
| Reconciled Depreciation | 1.4M | 4.2M | 4.6M | 3.6M | 3.2M | 2.8M | |
| Income Before Tax | (43.0M) | (44.1M) | (75.7M) | (64.9M) | (81.2M) | (77.2M) | |
| Total Other Income Expense Net | 8.0M | 9.2M | 6.0M | 8.2M | 16.5M | 17.3M | |
| Net Income Applicable To Common Shares | (43.0M) | (44.1M) | (75.7M) | (64.9M) | (58.4M) | (61.3M) | |
| Net Income | (34.1M) | (33.8M) | (75.7M) | (65.1M) | (81.6M) | (77.5M) | |
| Income Tax Expense | (8.9M) | (10.3M) | 1K | 230K | 368K | 386.4K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hookipa Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hookipa Pharma. If investors know Hookipa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hookipa Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.67) | Revenue Per Share 4.403 | Quarterly Revenue Growth (0.52) | Return On Assets (0.20) | Return On Equity (0.49) |
The market value of Hookipa Pharma is measured differently than its book value, which is the value of Hookipa that is recorded on the company's balance sheet. Investors also form their own opinion of Hookipa Pharma's value that differs from its market value or its book value, called intrinsic value, which is Hookipa Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hookipa Pharma's market value can be influenced by many factors that don't directly affect Hookipa Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hookipa Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hookipa Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hookipa Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.